Daniel Menichella
2020
In 2020, Daniel Menichella earned a total compensation of $3.9M as President and Chief Executive Officer principal executive officer at Kaleido Biosciences.
Compensation breakdown
Non-Equity Incentive Plan | $49,044 |
---|---|
Option Awards | $3,777,318 |
Salary | $118,731 |
Other | $1,734 |
Total | $3,946,827 |
Menichella received $3.8M in option awards, accounting for 96% of the total pay in 2020.
Menichella also received $49K in non-equity incentive plan, $118.7K in salary and $1.7K in other compensation.
Rankings
In 2020, Daniel Menichella's compensation ranked 2,890th out of 13,090 executives tracked by ExecPay. In other words, Menichella earned more than 77.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,890 out of 13,090 | 78th |
Division Manufacturing | 1,113 out of 5,624 | 80th |
Major group Chemicals And Allied Products | 413 out of 2,257 | 82nd |
Industry group Drugs | 357 out of 1,957 | 82nd |
Industry Biological Products, Except Diagnostic Substances | 93 out of 411 | 77th |
Source: SEC filing on May 5, 2021.
Menichella's colleagues
We found three more compensation records of executives who worked with Daniel Menichella at Kaleido Biosciences in 2020.